UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

Living Well With Stroke

Not Applicable

Completed

Conditions: Cerebrovascular Stroke
Depression

Interventions: Behavioral: Brief pleasurable events/behavioral therapy
Other: Standard care

First Posted Date: 2010-05-28

Last Posted Date: 2016-05-23

Lead Sponsor: University of Washington

Target Recruit Count: 100

Registration Number: NCT01133106

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Three Arm Trial of Immune Effects of Echinacea

Not Applicable

Completed

Conditions: Upper Respiratory Tract Infections

Interventions: Biological: Echinacea purpurea product
Biological: Placebo

First Posted Date: 2010-05-24

Last Posted Date: 2012-06-21

Lead Sponsor: University of Washington

Target Recruit Count: 67

Registration Number: NCT01129128

Locations: 🇺🇸
Bastyr University, Kenmore, Washington, United States

Efficacy Trial of Warrior Check-Up

Phase 2

Completed

Conditions: Alcohol Dependence
Alcohol Abuse
Substance Abuse
Substance Dependence

Interventions: Behavioral: Motivational Enhancement Therapy
Behavioral: Education

First Posted Date: 2010-05-21

Last Posted Date: 2015-05-27

Lead Sponsor: University of Washington

Target Recruit Count: 242

Registration Number: NCT01128140

Locations: 🇺🇸
University of Washington Innovative Programs Research Group, Seattle, Washington, United States

Community-based Intergenerational Oral Health Study

Phase 3

Conditions: Preventive Health Services

Interventions: Behavioral: motivational interviewing counseling
Behavioral: health education

First Posted Date: 2010-05-10

Last Posted Date: 2011-01-12

Lead Sponsor: University of Washington

Target Recruit Count: 400

Registration Number: NCT01120041

Locations: 🇺🇸
Jefferson County Public Health Department, Madras, Oregon, United States
🇺🇸
Douglas County Health & Social Services, Roseburg, Oregon, United States
🇺🇸
Josephine County Public Health Department, Grants Pass, Oregon, United States

and more 1 locations

Bendamustine Hydrochloride, Etoposide, Dexamethasone, and Filgrastim For Peripheral Blood Stem Cell Mobilization in Treating Patients With Refractory or Recurrent Lymphoma or Multiple Myeloma

Phase 2

Completed

Conditions: Nodal Marginal Zone B-cell Lymphoma
Peripheral T-cell Lymphoma
Recurrent Adult Burkitt Lymphoma
Recurrent Adult Diffuse Large Cell Lymphoma
Recurrent Adult Diffuse Mixed Cell Lymphoma
Recurrent Adult Diffuse Small Cleaved Cell Lymphoma
Recurrent Adult Grade III Lymphomatoid Granulomatosis
Recurrent Adult Hodgkin Lymphoma
Recurrent Adult Immunoblastic Large Cell Lymphoma
Recurrent Adult Lymphoblastic Lymphoma

Interventions: Drug: bendamustine hydrochloride
Drug: dexamethasone
Biological: filgrastim
Procedure: leukapheresis
Other: laboratory biomarker analysis
Other: flow cytometry
Drug: etoposide

First Posted Date: 2010-04-26

Last Posted Date: 2017-05-24

Lead Sponsor: University of Washington

Target Recruit Count: 43

Registration Number: NCT01110135

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

Subjective Analgesic Effects of Naloxone and Virtual Reality

Not Applicable

Conditions: Pain

Interventions: Drug: Placebo
Drug: naloxone

First Posted Date: 2010-04-19

Last Posted Date: 2012-08-21

Lead Sponsor: University of Washington

Target Recruit Count: 50

Registration Number: NCT01105871

Locations: 🇺🇸
University of Washington Medical Center, Seattle, Washington, United States

Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer

Phase 1

Completed

Conditions: Hereditary Breast/Ovarian Cancer - BRCA2
Estrogen Receptor-negative Breast Cancer
Hereditary Breast/Ovarian Cancer - BRCA1
Male Breast Cancer
HER2-negative Breast Cancer
Progesterone Receptor-negative Breast Cancer
Recurrent Breast Cancer
Stage IV Breast Cancer
Triple-negative Breast Cancer

Interventions: Drug: veliparib
Drug: cisplatin
Drug: vinorelbine tartrate
Other: laboratory biomarker analysis
Other: pharmacological study

First Posted Date: 2010-04-15

Last Posted Date: 2017-08-10

Lead Sponsor: University of Washington

Target Recruit Count: 50

Registration Number: NCT01104259

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

Self-collected Swabs for HPV Testing in 18-24 Year Old Women

Completed

Conditions: Papillomavirus Infections

First Posted Date: 2010-04-12

Last Posted Date: 2011-02-14

Lead Sponsor: University of Washington

Target Recruit Count: 150

Registration Number: NCT01101828

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative Neoplasm

Phase 2

Completed

Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
Adult Acute Myeloid Leukemia With Del(5q)
Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)
Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)
Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)
Chronic Myelomonocytic Leukemia
de Novo Myelodysplastic Syndromes
Refractory Anemia With Excess Blasts
Untreated Adult Acute Myeloid Leukemia

Interventions: Biological: filgrastim
Drug: clofarabine
Drug: cytarabine

First Posted Date: 2010-04-12

Last Posted Date: 2017-10-19

Lead Sponsor: University of Washington

Target Recruit Count: 50

Registration Number: NCT01101880

Locations: 🇺🇸
City of Hope Medical Center, Duarte, California, United States
🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
🇺🇸
Stanford University, Stanford, California, United States

Virtual Reality Hypnosis for Chronic Pain Reduction

Not Applicable

Completed

Conditions: Burns

Interventions: Behavioral: Virtual Reality Distraction for Chronic Pain
Behavioral: Virtual Reality Hypnosis for chronic pain

First Posted Date: 2010-04-07

Last Posted Date: 2017-05-12

Lead Sponsor: University of Washington

Target Recruit Count: 10

Registration Number: NCT01099657

Locations: 🇺🇸
Harborview Medical Center, Seattle, Washington, United States

Home Terms & Conditions Privacy Policy